A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2241-2248

  Wu, Xinghuo ^a   Yang, Shuhua ^a   Duan, Deyu ^a   Liu, Xianzhe ^a   Zhang, Yukun ^a   Wang, Jing ^a   Yang, Cao ^a   Jiang, Song ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bone marrow derived stem cell; Granulocyte colony stimulating factor; Mobilization; Osteonecrosis; Stem cell factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE; OSTEOCALCIN; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE NECROSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION;

ANIMALS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; NECROSIS; OSTEONECROSIS; RABBITS; STEM CELL FACTOR;

EID: 56449110544     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.071209     Document Type: Article

References (26)

1. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop 2007;78:206-10.
2. Kuehnle I, Goodell MA. The therapeutic potential of stem cells from adults. BMJ 2002;325:372-6.
3. Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005;241:506-15.
4. Adachi Y, Imagawa J, Suzuki Y, et al. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J Mol Cell Cardiol 2004;36:707-10.
5. Borue X, Lee S, Grove J, et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 2004;165:1767-72.
6. Gangji V, Hauzeur JP, Schoutens A, et al. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 2003;30:348-51.
7. Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 1999;81:349-55.
8. Gangji V, Hauzeur JP, Matos C, et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004;86:1153-60.
9. Anderson DM, Lyman SD, Baird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990;63:235-43.
10. Ulich TR, del Castillo J, Yi ES, et al. Hematologic effects of stem cell factor in vivo and in vitro in rodents. Blood 1991;78:645-50.
11. Verfaillie CM. Hematopoietic stem cells for transplantation. Nat Immunol 2002;3:314-7.
12. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9.
13. Qin L, Zhang G, Sheng H, et al. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone 2006;39:863-71.
14. Gangji V, Toungouz M, Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005;5:437-42.
15. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg 1999;7:250-61.
16. Brody AS, Strong M, Babikian G, et al. Avascular necrosis: early MR imaging and histologic findings in a canine model. AJR Am J Roentgenol 1991;157:341-5.
17. Koo KH, Jeong ST, Jones JP Jr. Borderline necrosis of the femoral head. Clin Orthop 1999;358:158-65.
18. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
19. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-7.
20. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6.
21. Glimcher MJ. Cell biology during repair of osteonecrosis: implications for rational treatment. Acta Orthop Belg 1999;65 Suppl:17-22.
22. Hofstaetter JG, Wang J, Yan J, Glimcher MJ. Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 2006;184:138-47.
23. Tang TT, Lu B, Yue B, et al. Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 2007;89:127-9.
24. Gehron Robey P, Boskey AL. The biochemistry of bone. In: Marcus R, Feldman D, editors. Osteoporosis. New York: Raven Press; 1996:95-184.
25. Ivaska KK, Hentunen TA, Vääräniemi J, et al. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004;279:18361-9.
26. Hernigou P, Lambotte JC. Volumetric analysis of osteonecrosis of the femur. Anatomical correlation using MRI. J Bone Joint Surg Br 2001,83:672-5.